BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1702360)

  • 21. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.
    Xu LL; Shanmugam N; Segawa T; Sesterhenn IA; McLeod DG; Moul JW; Srivastava S
    Genomics; 2000 Jun; 66(3):257-63. PubMed ID: 10873380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
    Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
    Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of complementary DNA clones for genes overexpressed in chemically induced rat hepatomas.
    Corral M; Defer N; Paris B; Raymondjean M; Corcos D; Tichonicky L; Kruh J; Glaise D; Kneip B; Guguen-Guillouzo C
    Cancer Res; 1986 Oct; 46(10):5119-24. PubMed ID: 2428472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of NK cell or NK/T cell-specific cDNA clones.
    Houchins JP; Yabe T; McSherry C; Miyokawa N; Bach FH
    J Mol Cell Immunol; 1990; 4(6):295-304; discussion 305-6. PubMed ID: 2080984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.
    Tang XX; Biegel JA; Nycum LM; Yoshioka A; Brodeur GM; Pleasure DE; Ikegaki N
    Genomics; 1995 Sep; 29(2):426-37. PubMed ID: 8666391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer.
    Ren C; Yang G; Timme TL; Wheeler TM; Thompson TC
    Cancer Res; 1998 Mar; 58(6):1285-90. PubMed ID: 9515817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
    Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
    Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A; Sood AK
    Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
    Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
    Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of vimentin in rat prostatic tumors.
    Bussemakers MJ; Verhaegh GW; van Bokhoven A; Debruyne FM; Schalken JA
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1254-9. PubMed ID: 1540169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of an improved cDNA competition technique to identify prostate cancer-associated gene.
    Rinaldy AR; Steiner MS
    DNA Cell Biol; 1999 Nov; 18(11):829-36. PubMed ID: 10595396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the rat homologue of KAI1 and its expression in Dunning rat prostate cancers.
    Suzuki H; Dong JT; Gao AC; Barrett JC; Isaacs JT
    Prostate; 1998 Dec; 37(4):253-60. PubMed ID: 9831222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct profiling of cancer biomarkers in tumor tissue using a multiplexed nanostructured microelectrode integrated circuit.
    Fang Z; Soleymani L; Pampalakis G; Yoshimoto M; Squire JA; Sargent EH; Kelley SO
    ACS Nano; 2009 Oct; 3(10):3207-13. PubMed ID: 19736919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model.
    Doyle GM; Sharief Y; Mohler JL
    J Urol; 1992 Feb; 147(2):514-8. PubMed ID: 1732634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the abundance of variably spliced transcripts for the second asialoglycoprotein receptor polypeptide, H2, in normal and transformed human liver.
    Paietta E; Stockert RJ; Racevskis J
    Hepatology; 1992 Mar; 15(3):395-402. PubMed ID: 1371982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell surface charge in predicting metastatic potential of aspirated cells from the Dunning rat prostatic adenocarcinoma model.
    Carter HB; Coffey DS
    J Urol; 1988 Jul; 140(1):173-5. PubMed ID: 3379685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array.
    Piétu G; Alibert O; Guichard V; Lamy B; Bois F; Leroy E; Mariage-Sampson R; Houlgatte R; Soularue P; Auffray C
    Genome Res; 1996 Jun; 6(6):492-503. PubMed ID: 8828038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of new prostate cancer progression markers by differential hybridization analysis.
    Schalken JA; Debruyne FM
    Eur Urol; 1992; 21 Suppl 1():60-5. PubMed ID: 1425840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.
    Adamo HH; Strömvall K; Nilsson M; Halin Bergström S; Bergh A
    PLoS One; 2015; 10(11):e0141601. PubMed ID: 26536349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.